We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$25.2B
AUM Growth
-$335M
(-1.3%)
Cap. Flow
-$2.05B
Cap. Flow
% of AUM
-8.13%
Top 10 Holdings %
Top 10 Hldgs %
26.87%
Holding
1,147
New
127
Increased
298
Reduced
504
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$160M |
| 2 |
Masco
MAS
|
+$134M |
| 3 |
Lam Research
LRCX
|
+$112M |
| 4 |
Coupang
CPNG
|
+$101M |
| 5 |
Nu Holdings
NU
|
+$98.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$205M |
| 2 |
Lennox International
LII
|
+$191M |
| 3 |
NVIDIA
NVDA
|
+$169M |
| 4 |
Tractor Supply
TSCO
|
+$157M |
| 5 |
Apple
AAPL
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.69% |
| 2 | Consumer Discretionary | 12.85% |
| 3 | Industrials | 12.71% |
| 4 | Financials | 12.68% |
| 5 | Healthcare | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Cummins
CMI
$88.5B
| $16.3M | 0.06% |
38,550
-47,066
| -55% | -$18M |
|
|
SNV
227
DELISTED
Synovus
SNV
| $16.2M | 0.06% |
330,647
-2,226
| -0.7% | -$114K |
|
228
First Industrial Realty Trust
FR
$8.77B
| $15.9M | 0.06% |
308,977
-130,242
| -30% | -$6.54M |
|
229
American Homes 4 Rent
AMH
$12.2B
| $15.9M | 0.06% |
+477,243
| New | +$16.6M |
|
230
Acadia Pharmaceuticals
ACAD
$4.45B
| $15.8M | 0.06% |
742,078
-19,106
| -3% | -$452K |
|
231
Dillards
DDS
$9.2B
| $15.8M | 0.06% |
25,687
+87
| +0.3% | +$45K |
|
232
Etsy
ETSY
$8.21B
| $15.7M | 0.06% |
236,705
+46,364
| +24% | +$2.77M |
|
233
Berkshire Hathaway Class B
BRK.B
$1.11T
| $15.7M | 0.06% |
31,165
-45,327
| -59% | -$22M |
|
|
TMHC
234
DELISTED
Taylor Morrison
TMHC
| $15.6M | 0.06% |
236,091
+5,928
| +3% | +$390K |
|
235
Silicon Laboratories
SLAB
$7.17B
| $15.6M | 0.06% |
118,632
+5,659
| +5% | +$771K |
|
236
Pinnacle West Capital
PNW
$12.8B
| $15.5M | 0.06% |
173,184
-138,962
| -45% | -$12.5M |
|
237
Centene
CNC
$31.6B
| $15.4M | 0.06% |
+432,708
| New | +$13.1M |
|
238
Arcus Biosciences
RCUS
$3.4B
| $15.2M | 0.06% |
1,120,062
+314,757
| +39% | +$3.27M |
|
239
Schneider National
SNDR
$6.34B
| $15.2M | 0.06% |
719,413
-310,044
| -30% | -$7.58M |
|
240
Broadridge
BR
$18.3B
| $15.2M | 0.06% |
+63,908
| New | +$15.9M |
|
|
XHR
241
Xenia Hotels & Resorts
XHR
$2.01B
| $15.2M | 0.06% |
1,108,891
-109,628
| -9% | -$1.49M |
|
242
Autoliv
ALV
$9.09B
| $15.1M | 0.06% |
+122,157
| New | +$14.6M |
|
243
Evolent Health
EVH
$421M
| $15M | 0.06% |
1,773,818
+1,102,264
| +164% | +$10.7M |
|
244
Accenture
ACN
$101B
| $14.8M | 0.06% |
60,205
-241,008
| -80% | -$62.8M |
|
|
DCH
245
Dauch Corp
DCH
$1.33B
| $14.6M | 0.06% |
2,435,065
+1,007,977
| +71% | +$5.4M |
|
246
Fluence Energy
FLNC
$1.68B
| $14.2M | 0.06% |
+1,315,443
| New | +$11M |
|
247
Astrana Health
ASTH
$1.88B
| $14.2M | 0.06% |
500,527
+80,465
| +19% | +$2.18M |
|
248
Twist Bioscience
TWST
$5.51B
| $14M | 0.06% |
497,138
+134,929
| +37% | +$4.09M |
|
249
Amkor Technology
AMKR
$11.3B
| $13.6M | 0.05% |
479,850
-1,200,455
| -71% | -$28.9M |
|
250
Madison Square Garden
MSGE
$3.65B
| $13.5M | 0.05% |
298,241
-59,163
| -17% | -$2.4M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2025 Portfolio in Review
As of Q3 2025, Jacobs Levy Equity Management held 1,147 positions worth $25.2B, down 1.3% from $25.5B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jacobs Levy Equity Management withdrew a net $2.05B in Q3 2025, closing 194 positions and reducing 504 holdings. Its most notable exit was Progressive, an estimated $66.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bank of America worth $45M.
- Jacobs Levy Equity Management's largest Q3 2025 buy was Bank of America: 873,228 shares worth $45M.
- Jacobs Levy Equity Management added most to Alnylam Pharmaceuticals in Q3 2025, an estimated $160M increase.
- Jacobs Levy Equity Management's biggest Q3 2025 reduction was GE Vernova, cutting an estimated $205M.
- Jacobs Levy Equity Management fully exited Progressive in Q3 2025, selling an estimated $66.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 27% of its $25.2B portfolio in Q3 2025.
- Jacobs Levy Equity Management opened 127 new positions and closed 194 in Q3 2025.
- Jacobs Levy Equity Management's portfolio value fell 1.3% quarter-over-quarter to $25.2B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.